CW
COGT icon

Connectus Wealth’s Cogent Biosciences COGT Stock Holding History

Connectus Wealth’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$78.1K Buy
+11,628
New +$71.9K ﹤0.01% 364

Other funds holding COGT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Connectus Wealth's COGT Position: Q1 2024 in Review

Connectus Wealth opened a new position in Cogent Biosciences (COGT) in Q1 2024: 11,628 shares worth $78.1K. The stake represents ﹤0.01% of the portfolio and ranks #364 among its holdings.

146 funds tracked by Wall St. Rank hold COGT as of Q1 2024.

  • Connectus Wealth held 11,628 shares of Cogent Biosciences worth $78.1K as of Q1 2024.
  • Cogent Biosciences was a new Connectus Wealth position in Q1 2024.
  • Cogent Biosciences made up ﹤0.01% of Connectus Wealth's portfolio in Q1 2024, its #364 holding.
  • 146 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.